HPS Pharmacies wish to advise that all sponsors are currently experiencing a supply interruption for ezetimibe 10mg tablets.
Normal supplies are expected to return in mid-October 2024 for some brands, although other brands are not expected to return until mid-November 2024.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is registered for use in the United States and all packaging is in English.
Some ezetimibe combination products may also be affected by supply issues during this period.
Retain this notice in a prominent position, including in other related business units, until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates